Springhill Fund Asset Management (HK) Co Ltd 13F Holdings · last filed Q1 2025
Springhill Fund Asset Management (HK) Co Ltd reported 19 securities worth $20.87M in its SEC 13F filing for Q1 2025 (period ended 2025-03-31). Top holdings: VRNA (19.32%), SMMT (11.49%), JANX (10.16%). Among its top 25 positions this quarter: 13 new, 2 added, 4 trimmed, 6 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | VRNA | VERONA PHARMA PLC | $4.0M | 19.32% | 63,499 | Trimmed |
| 2 | SMMT | SUMMIT THERAPEUTICS INC | $2.4M | 11.49% | 124,307 | New |
| 3 | JANX | JANUX THERAPEUTICS INC | $2.1M | 10.16% | 78,500 | Added |
| 4 | REGN | REGENERON PHARMACEUTICALS | $1.6M | 7.90% | 2,600 | New |
| 5 | NBIX | NEUROCRINE BIOSCIENCES INC | $1.5M | 7.21% | 13,612 | New |
| 6 | INSM | INSMED INC | $1.5M | 7.02% | 19,192 | Trimmed |
| 7 | SLNO | SOLENO THERAPEUTICS INC | $1.4M | 6.80% | 19,858 | Added |
| 8 | JAZZ | JAZZ PHARMACEUTICALS PLC | $1.2M | 5.86% | 9,853 | New |
| 9 | AKRO | AKERO THERAPEUTICS INC | $806,564 | 3.87% | 19,925 | Trimmed |
| 10 | ARGX | ARGENX SE | $678,277 | 3.25% | 1,146 | New |
| 11 | LLY | ELI LILLY & CO | $673,943 | 3.23% | 816 | New |
| 12 | PTGX | PROTAGONIST THERAPEUTICS INC | $621,861 | 2.98% | 12,859 | New |
| 13 | TGTX | TG THERAPEUTICS INC | $532,305 | 2.55% | 13,500 | New |
| 14 | TARS | TARSUS PHARMACEUTICALS INC | $363,494 | 1.74% | 7,076 | New |
| 15 | ASND | ASCENDIS PHARMA A/S | $338,684 | 1.62% | 2,173 | New |
| 16 | RYTM | RHYTHM PHARMACEUTICALS INC | $332,493 | 1.59% | 6,277 | New |
| 17 | BNTX | BIONTECH SE | $273,180 | 1.31% | 3,000 | New |
| 18 | SWTX | SPRINGWORKS THERAPEUTICS INC | $260,235 | 1.25% | 5,897 | New |
| 19 | COGT | COGENT BIOSCIENCES INC | $176,651 | 0.85% | 29,491 | Trimmed |
| 20 | ABVX | ABIVAX SA | $0 | 0.00% | 0 | Exited |
| 21 | AZN | ASTRAZENECA PLC | $0 | 0.00% | 0 | Exited |
| 22 | BCYC | BICYCLE THERAPEUTICS PLC | $0 | 0.00% | 0 | Exited |
| 23 | CGEM | CULLINAN THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 24 | CYTK | CYTOKINETICS INC | $0 | 0.00% | 0 | Exited |
| 25 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2025-03-31
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR